Eton Pharmaceuticals Inc.
ETON | NASDAQ
$55.31
-$0.19 (-0.34%)
At close: Sep 21, 2026, 4:00 PM ET
$55.70
+$0.39 (+0.71%)
Pre-market:
Sep 22, 2026, 5:57 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 79.95M | 39.01M | 31.64M | 21.25M | 21.83M | 39K |
Cost of Revenue | 37.21M | 15.6M | 10.58M | 6.93M | 2.62M | 286K |
Gross Profit | 42.74M | 23.41M | 21.06M | 14.32M | 19.21M | -247K |
Operating Income | 72K | -2.6M | -1.19M | -8.26M | -1.5M | -27.11M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.56M | -3.81M | -689K | -9.02M | -1.96M | -27.97M |
Net Income | -4.6M | -3.82M | -936K | -9.02M | -1.96M | -27.97M |
Selling & General & Admin | 35.82M | 22.75M | 18.93M | 18.58M | 14.47M | 12.76M |
Research & Development | 7.77M | 3.26M | 3.32M | 4M | 6.24M | 14.1M |
Other Expenses | -916K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 42.67M | 26.01M | 22.25M | 22.58M | 20.7M | 26.86M |
Interest Expense | 4.78M | 2.01M | 1.06M | 955K | 1.04M | 889K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 79.88M | 41.61M | 32.83M | 29.51M | 23.33M | 27.15M |
Income Tax Expense | 43K | 15K | 247K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 26.91M | 25.9M | 25.65M | 25.15M | 25.21M | 21.01M |
Shares Outstanding (Diluted) | 26.91M | 25.9M | 25.65M | 25.15M | 25.21M | 21.01M |
EPS (Basic) | -0.17 | -0.15 | -0.04 | -0.36 | -0.08 | -1.33 |
EPS (Diluted) | -0.17 | -0.15 | -0.04 | -0.36 | -0.08 | -1.33 |
EBITDA | 4.27M | -657K | 212K | -7.25M | -1.49M | -26.46M |
EBIT | 223K | -1.8M | -689K | -9.02M | -1.96M | -27.11M |
Depreciation & Amortization | 4.04M | 1.15M | 901K | 1.77M | 462K | 651K |
Add to Watchlist
Select watchlists to add or remove ETON